{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","metadata_created":"2018-12-27T18:40:32.157399","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2018-12-27T18:40:32.157408","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2018-12-27","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Infection","Tuberculeuse latente","Schéma thérapeutique court","À risque","Canadiens","Canada","Consommateurs de drogues","Sans-abri","Contamination d’échangeurs thermiques","Mycobactéries non tuberculeuses","tuberculose active"],"en":["Latent tuberculosis","Infection","Shorter treatment regimen","At-risk","Canadians","Canada","Outbreak","Substance users","Homeless","Device testing recommendations","Non-tuberculous Mycobacteria (NTM) contamination","Heater-cooler units","Active tuberculosis","TB"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 43-3/4, le 2 mars 2017 : Tuberculose","en":"CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1b2b3d3a-0cb4-48a5-8b27-2b4f447b05f1","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-3/4, le 2 mars 2017 : Tuberculose","en":"CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)","language":["en"],"created":"2018-12-27T18:40:33.257389","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-3-4-march-2-2017.html","last_modified":null,"position":0,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fad365b9-6abb-44b1-b3cf-e66e2f3be23d","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-3/4, le 2 mars 2017 : Tuberculose","en":"CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)","language":["fr"],"created":"2018-12-27T18:40:33.257397","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-3-4-2-mars-2017.html","last_modified":null,"position":1,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b04d3773-970f-412a-aa74-3dbe4c0222b0","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-3/4, le 2 mars 2017 : Tuberculose","en":"CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)","language":["en"],"created":"2018-12-27T18:40:33.257401","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/17vol43/dr-rm43-3-4/assets/pdf/17vol43_3_4-eng.pdf","last_modified":null,"position":2,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"62ae608e-2408-4eb1-9467-b1509b0fa186","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-3/4, le 2 mars 2017 : Tuberculose","en":"CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)","language":["fr"],"created":"2018-12-27T18:40:33.257403","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/17vol43/dr-rm43-3-4/assets/pdf/17vol43_3_4-fra.pdf","last_modified":null,"position":3,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"68694a2e-832c-4b47-9b13-3ae6037e9df5","related_relationship":"","name_translated":{"fr":"L’infection tuberculeuse latente : un aperçu","en":"Latent tuberculosis infection: An overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Latent tuberculosis infection: An overview","language":["en"],"created":"2018-12-27T18:40:33.257406","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-3-4-march-2-2017/ccdr-volume-43-3-4-march-2-2017-tuberculosis-5.html","last_modified":null,"position":4,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"db0d1ba6-2b8e-4ba4-9df9-a3b037faaee2","related_relationship":"","name_translated":{"fr":"L’infection tuberculeuse latente : un aperçu","en":"Latent tuberculosis infection: An overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Latent tuberculosis infection: An overview","language":["fr"],"created":"2018-12-27T18:40:33.257408","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-3-4-2-mars-2017/rmtc-volume-43-3-4-2-mars-2017-tuberculose-5.html","last_modified":null,"position":5,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"17ba590b-af85-496f-9544-7cdcdf74c9bb","related_relationship":"","name_translated":{"fr":"Un schéma thérapeutique plus court pour le traitement de l'infection tuberculeuse latente","en":"Shorter treatment regimen for latent tuberculosis infection"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Shorter treatment regimen for latent tuberculosis infection","language":["en"],"created":"2018-12-27T18:40:33.257411","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-3-4-march-2-2017/ccdr-volume-43-3-4-march-2-2017-tuberculosis-2.html","last_modified":null,"position":6,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6730e9f7-4fbf-4369-b233-37d50e1d86e1","related_relationship":"","name_translated":{"fr":"Un schéma thérapeutique plus court pour le traitement de l'infection tuberculeuse latente","en":"Shorter treatment regimen for latent tuberculosis infection"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Shorter treatment regimen for latent tuberculosis infection","language":["fr"],"created":"2018-12-27T18:40:33.257413","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-3-4-2-mars-2017/rmtc-volume-43-3-4-2-mars-2017-tuberculose-2.html","last_modified":null,"position":7,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6dbb7bbb-33b5-4bbf-96ea-f16d33a25f1a","related_relationship":"","name_translated":{"fr":"Éclosion de tuberculose chez les consommateurs de drogues et les sans-abri du Grand Montréal, Canada, de 2003 à 2016","en":"Tuberculosis among substance users and homeless people in Montréal, Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis among substance users and homeless people in Montréal, Canada","language":["en"],"created":"2018-12-27T18:40:33.257415","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-3-4-march-2-2017/ccdr-volume-43-3-4-march-2-2017-tuberculosis-3.html","last_modified":null,"position":8,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3f01604f-476c-4d1b-b85c-7c3353970bd6","related_relationship":"","name_translated":{"fr":"Éclosion de tuberculose chez les consommateurs de drogues et les sans-abri du Grand Montréal, Canada, de 2003 à 2016","en":"Tuberculosis among substance users and homeless people in Montréal, Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis among substance users and homeless people in Montréal, Canada","language":["fr"],"created":"2018-12-27T18:40:33.257418","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-3-4-2-mars-2017/rmtc-volume-43-3-4-2-mars-2017-tuberculose-3.html","last_modified":null,"position":9,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4ed31111-8b03-4c7e-a28c-515d845d285d","related_relationship":"","name_translated":{"fr":"La tuberculose au Canada - Résumé 2015","en":"Tuberculosis in Canada - Summary 2015"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis in Canada - Summary 2015","language":["en"],"created":"2018-12-27T18:40:33.257420","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-3-4-march-2-2017/ccdr-volume-43-3-4-march-2-2017-tuberculosis-1.html","last_modified":null,"position":10,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"dataset"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2a8f6380-bdad-40e1-8b9f-9207d5202874","related_relationship":"","name_translated":{"fr":"La tuberculose au Canada - Résumé 2015","en":"Tuberculosis in Canada - Summary 2015"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis in Canada - Summary 2015","language":["fr"],"created":"2018-12-27T18:40:33.257422","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-3-4-2-mars-2017/rmtc-volume-43-3-4-2-mars-2017-tuberculose-1.html","last_modified":null,"position":11,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"dataset"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"85847c7d-a542-4a0c-9582-0ddd3d348512","related_relationship":"","name_translated":{"fr":"Recommandations du RLSPC au sujet de la contamination d’échangeurs thermiques par des mycobactéries non tuberculeuses","en":"CPHLN device testing recommendations regarding non-tuberculous Mycobacteria (NTM) contamination in heater-cooler units"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CPHLN device testing recommendations regarding non-tuberculous Mycobacteria (NTM) contamination in heater-cooler units","language":["en"],"created":"2018-12-27T18:40:33.257425","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-3-4-march-2-2017/ccdr-volume-43-3-4-march-2-2017-tuberculosis.html#a1","last_modified":null,"position":12,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"24930f2c-a011-455a-bb92-7ff2e936aafa","related_relationship":"","name_translated":{"fr":"Recommandations du RLSPC au sujet de la contamination d’échangeurs thermiques par des mycobactéries non tuberculeuses","en":"CPHLN device testing recommendations regarding non-tuberculous Mycobacteria (NTM) contamination in heater-cooler units"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CPHLN device testing recommendations regarding non-tuberculous Mycobacteria (NTM) contamination in heater-cooler units","language":["fr"],"created":"2018-12-27T18:40:33.257427","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-3-4-2-mars-2017/rmtc-volume-43-3-4-2-mars-2017-tuberculose.html#a1","last_modified":null,"position":13,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"71fceb1c-7204-44e8-be8f-4655560cf4ca","related_relationship":"","name_translated":{"fr":"Appel à contributions du RMTC","en":"CCDR call for submissions"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR call for submissions","language":["en"],"created":"2018-12-27T18:40:33.257430","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-3-4-march-2-2017/ccdr-volume-43-3-4-march-2-2017-tuberculosis.html#a2","last_modified":null,"position":14,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7c4a60a8-75dd-4cd2-a40f-383e4d6b2412","related_relationship":"","name_translated":{"fr":"Appel à contributions du RMTC","en":"CCDR call for submissions"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR call for submissions","language":["fr"],"created":"2018-12-27T18:40:33.257432","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-3-4-2-mars-2017/rmtc-volume-43-3-4-2-mars-2017-tuberculose.html#a2","last_modified":null,"position":15,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"93acf4d6-75fd-4c01-8132-9594b75d35b2","related_relationship":"","name_translated":{"fr":"Marqueurs permettant de différencier la tuberculose active de l’infection latente","en":"Markers that may differentiate active from latent TB"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Markers that may differentiate active from latent TB","language":["en"],"created":"2018-12-27T18:40:33.257435","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-3-4-march-2-2017/ccdr-volume-43-3-4-march-2-2017-tuberculosis-6.html","last_modified":null,"position":16,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"35be12df-4204-4c6d-ae6b-67466bb04a12","related_relationship":"","name_translated":{"fr":"Marqueurs permettant de différencier la tuberculose active de l’infection latente","en":"Markers that may differentiate active from latent TB"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Markers that may differentiate active from latent TB","language":["fr"],"created":"2018-12-27T18:40:33.257437","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-3-4-2-mars-2017/rmtc-volume-43-3-4-2-mars-2017-tuberculose-6.html","last_modified":null,"position":17,"revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9","resource_type":"website"}],"place_of_publication":[],"num_resources":18,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2017-03-02 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"d1d42cbc-3ee0-44cd-87d1-ff8e031d55be","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. ","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 43-3/4, March 2, 2017: Tuberculosis (TB)","revision_id":"182c6464-e4bc-4702-90ef-42c13d2a35e9"}